Skip to content
healthcare.dev

Nabumetone

NDC 50228-465, Nabumetone, tablet, from ScieGen Pharmaceuticals Inc.

Product NDC
50228-465
Status
Listed
Labeler
ScieGen Pharmaceuticals Inc
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078420
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50228-465 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NABUMETONE500 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
50228-465-0150228046501100 TABLET in 1 BOTTLE (50228-465-01)
50228-465-0550228046505500 TABLET in 1 BOTTLE (50228-465-05)
50228-465-305022804653030 TABLET in 1 BOTTLE (50228-465-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/80c6888d-03b4-44f3-b94d-bcf5154ceae5
  • NADAC price for package 50228046501

    GET /v1/drugs/nadac/50228046501
  • NADAC price for package 50228046505

    GET /v1/drugs/nadac/50228046505

Use it

Look up 50228-465 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50228-465 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50228-465. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.